Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

CHE

Chemed Corp

Sep 15 • 04:00PM ET

442.24

-4.16 -0.93 %

Healthcare • Medical Care Facilities • USA • NYSE

Peers: ENSG EHC HCA SEM AMED HUM TDOC CYH ACHC UHS

| Held by: IJH VTI VB VBK VXF SDVY MDY XMHQ REGL VIG

Scroll to Statements

Index	-	P/E	22.74	EPS (ttm)	19.45	Insider Own	1.93%	Shs Outstand	14.52M	Perf Week	-4.64%
Market Cap	6.44B	Forward P/E	17.47	EPS next Y	25.32	Insider Trans	-5.85%	Shs Float	14.29M	Perf Month	-0.37%
Enterprise Value	6.34B	PEG	4.31	EPS next Q	5.36	Inst Own	97.02%	Short Float	2.87%	Perf Quarter	-19.76%
Income	290.35M	P/S	2.57	EPS this Y	-4.37%	Inst Trans	0.44%	Short Ratio	2.19	Perf Half Y	-26.07%
Sales	2.51B	P/B	5.36	EPS next Y	14.46%	ROA	16.82%	Short Interest	0.41M	Perf YTD	-16.53%
Book/sh	82.56	P/C	25.79	EPS next 5Y	5.28%	ROE	24.14%	52W High	623.60 -29.08%	Perf Year	-22.03%
Cash/sh	17.15	P/FCF	17.35	EPS past 3/5Y	5.68% 8.37%	ROIC	22.33%	52W Low	408.42 8.28%	Perf 3Y	-6.64%
Dividend Est.	2.05 (0.46%)	EV/EBITDA	14.65	Sales past 3/5Y	4.36% 4.63%	Gross Margin	31.11%	Volatility	2.42% 1.99%	Perf 5Y	-10.05%
Dividend TTM	2.10 (0.47%)	EV/Sales	2.52	EPS Y/Y TTM	-1.52%	Oper. Margin	14.69%	ATR (14)	10.53	Perf 10Y	227.25%
Dividend Ex-Date	Aug 11, 2025	Quick Ratio	1.83	Sales Y/Y TTM	7.55%	Profit Margin	11.56%	RSI (14)	41.68	Recom	1.00
Dividend Gr. 3/5Y	8.74% 7.74%	Current Ratio	1.86	EPS Q/Q	-23.19%	SMA20	-2.89%	Beta	0.43	Target Price	578.50
Payout	9.05%	Debt/Eq	0.12	Sales Q/Q	3.85%	SMA50	-1.99%	Rel Volume	1.27	Prev Close	446.40
Employees	15695	LT Debt/Eq	0.08	Earnings	Jul 29 AMC	SMA200	-17.36%	Avg Volume	187.54K	Price	442.24
IPO	Jun 29, 1982	Option/Short	Yes / Yes	EPS/Sales Surpr.	-16.60% -1.56%	Trades		Volume	235,121	Change	-0.93%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-02-25	Upgrade	Jefferies	Hold → Buy	$550
Jul-25-25	Initiated	Jefferies	Hold	$500
Mar-11-20	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$448 → $535
Nov-01-19	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$490
Sep-06-19	Reiterated	BofA/Merrill	Buy	$470 → $500
Oct-12-18	Initiated	BofA/Merrill	Buy	$390
Aug-28-17	Initiated	KeyBanc Capital Mkts	Sector Weight
Nov-01-16	Reiterated	RBC Capital Mkts	Sector Perform	$162 → $148
Jul-27-16	Reiterated	RBC Capital Mkts	Sector Perform	$136 → $162
May-02-16	Reiterated	RBC Capital Mkts	Sector Perform	$135 → $136
Oct-26-15	Reiterated	RBC Capital Mkts	Sector Perform	$129 → $154
Oct-26-15	Reiterated	Oppenheimer	Outperform	$150 → $152
Sep-22-15	Reiterated	Oppenheimer	Outperform	$147 → $150
Jul-27-15	Reiterated	RBC Capital Mkts	Sector Perform	$110 → $129
Feb-19-15	Reiterated	Oppenheimer	Outperform	$122 → $123
Sep-23-14	Reiterated	Oppenheimer	Outperform	$110 → $115
Jun-10-14	Reiterated	RBC Capital Mkts	Sector Perform	$70 → $74
May-01-14	Reiterated	Oppenheimer	Outperform	$90 → $92
Sep-10-13	Reiterated	Deutsche Bank	Hold	$70 → $63
Mar-04-11	Reiterated	Barclays Capital	Underweight	$65 → $9

Show Previous Ratings

Sep-02-25 03:35PM	Why Chemed (CHE) Stock Is Up Today (StockStory)
Aug-28-25 11:30AM	Why Is Chemed (CHE) Up 9.3% Since Last Earnings Report? (Zacks)
Aug-13-25 12:15AM	CHE Q2 Deep Dive: Margin Pressure, Medicare Cap Challenges, and Strategic Repositioning (StockStory)
Aug-12-25 11:42PM	5 Insightful Analyst Questions From Chemed's Q2 Earnings Call (StockStory)
Aug-10-25 11:31PM	Q2 Earnings Outperformers: Chemed (NYSE:CHE) And The Rest Of The Senior Health, Home Health & Hospice Stocks (StockStory)
12:50PM	Loading…
Aug-01-25 12:50PM	Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 60 Cents (Business Wire)
Jul-31-25 03:20AM	Chemed Corp (CHE) Q2 2025 Earnings Call Highlights: Navigating Challenges and Strategic Growth (GuruFocus.com)
Jul-30-25 04:22PM	VITAS® Healthcare Announces CEO Transition and Appointment of New Chief Executive Officer (GlobeNewswire) -10.36%
02:49PM	Why Chemed Stock Is Plummeting Today (Motley Fool)
01:41PM	Why Chemed (CHE) Stock Is Trading Lower Today (StockStory)
Jul-29-25 06:13PM	Chemed's (NYSE:CHE) Q2 Earnings Results: Revenue In Line With Expectations But Stock Drops (StockStory)
06:00PM	Chemed (CHE) Q2 Earnings Miss Estimates (Zacks)
04:56PM	Chemed: Q2 Earnings Snapshot (Associated Press Finance)
04:15PM	Chemed Reports Second-Quarter 2025 Results and Announces Executive Management Departure (Business Wire)
Jul-28-25 11:40AM	ASTH vs. CHE: Which Stock Is the Better Value Option? (Zacks)
11:02PM	Loading…
Jul-27-25 11:02PM	Chemed (CHE) Q2 Earnings: What To Expect (StockStory)
10:11AM	Chemed updates 2025 forecast as Q1 revenue shows continued growth (Insider Monkey)
Jul-24-25 10:27AM	Chemed Corporation (CHE): A Bull Case Theory (Insider Monkey)
Jul-23-25 08:07AM	Chemed (CHE) Fell due to Concerns Over Potential Medicare Cap Limits (Insider Monkey)
Jul-22-25 10:00AM	Analysts Estimate Chemed (CHE) to Report a Decline in Earnings: What to Look Out for (Zacks)
Jul-17-25 10:38AM	RBC Capital Lowered Firm's PT on Chemed Corporation (CHE), Kept a Buy Rating (Insider Monkey)
Jul-10-25 11:40AM	ASTH or CHE: Which Is the Better Value Stock Right Now? (Zacks)
Jun-30-25 01:47PM	Why Chemed (CHE) Shares Are Plunging Today (StockStory) -12.95%
Jun-27-25 04:15PM	Chemed To Report Second-Quarter 2025 Earnings July 29, 2025 (Business Wire)
07:59AM	Reasons to Add Align Technology Stock to Your Portfolio Now (Zacks)
Jun-20-25 09:48AM	5 Must-Read Analyst Questions From Chemed's Q1 Earnings Call (StockStory)
Jun-08-25 11:31PM	Senior Health, Home Health & Hospice Stocks Q1 In Review: Chemed (NYSE:CHE) Vs Peers (StockStory)
Jun-06-25 12:02AM	3 Reasons CHE is Risky and 1 Stock to Buy Instead (StockStory)
May-23-25 11:40AM	AMED or CHE: Which Is the Better Value Stock Right Now? (Zacks)
11:30AM	Chemed (CHE) Up 2.7% Since Last Earnings Report: Can It Continue? (Zacks)
02:53PM	Loading…
May-19-25 02:53PM	Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend (Business Wire)
May-14-25 12:00PM	Chemed Corporation to Present at the 2025 RBC Global Healthcare Conference (Business Wire)
May-06-25 12:00PM	Chemed Corporation to Present at the Bank of America Securities Health Care Conference 2025 (Business Wire)
May-02-25 09:00PM	LRT Capital Management April 2025 Investor Update (Seeking Alpha)
11:40AM	OPCH vs. CHE: Which Stock Is the Better Value Option? (Zacks)
12:40AM	3 Cash-Heavy Stocks Skating on Thin Ice (StockStory)
Apr-29-25 09:06AM	3 Dawdling Stocks That Concern Us (StockStory)
Apr-28-25 03:03AM	Option Care Health (OPCH) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Apr-25-25 10:18AM	CHE Stock Falls Despite Q1 Earnings & Revenue Beat, Gross Margin Declines (Zacks)
12:11AM	Q1 2025 Chemed Corp Earnings Call (Thomson Reuters StreetEvents)
Apr-24-25 04:14PM	Chemed Corporation (CHE) Q1 2025 Earnings Call Transcript (Seeking Alpha) -6.61%
09:15AM	Chemed Corporation (CHE): A Bull Case Theory (Insider Monkey)
Apr-23-25 05:45PM	Chemed (CHE) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
05:02PM	Chemed's (NYSE:CHE) Q1 Sales Beat Estimates (StockStory)
04:43PM	Chemed: Q1 Earnings Snapshot (Associated Press Finance)
04:15PM	Chemed Reports First-Quarter 2025 Results (Business Wire)
Apr-22-25 08:03AM	Chemed (CHE) Reports Earnings Tomorrow: What To Expect (StockStory)
Apr-15-25 05:01AM	Q4 Earnings Highs And Lows: Chemed (NYSE:CHE) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks (StockStory)
Apr-14-25 03:15PM	Aristotle Small/Mid Cap Equity Q1 2025 Commentary (Seeking Alpha)
11:40AM	OPCH or CHE: Which Is the Better Value Stock Right Now? (Zacks)
Apr-07-25 08:17AM	Chemed Corporation (CHE) Shares Retreated by -13% During TimesSquare U.S. FOCUS Growth Strategy's Holding Period (Insider Monkey)
Apr-03-25 05:05AM	Chemed (CHE): Buy, Sell, or Hold Post Q4 Earnings? (StockStory)
Apr-01-25 12:00PM	Chemed To Report First-Quarter 2025 Earnings April 23, Related Conference Call To Be Held On April 24 (Business Wire)
Mar-28-25 11:30AM	Why Is Chemed (CHE) Up 4.5% Since Last Earnings Report? (Zacks)
Mar-20-25 11:40AM	OPCH vs. CHE: Which Stock Is the Better Value Option? (Zacks)
Mar-18-25 09:01AM	2 Healthcare Stocks with Solid Fundamentals and 1 to Brush Off (StockStory)
Mar-12-25 05:02AM	Senior Health, Home Health & Hospice Stocks Q4 Teardown: AdaptHealth (NASDAQ:AHCO) Vs The Rest (StockStory)
Mar-03-25 01:24PM	Chemed Corporation to Present at the Oppenheimer 35th Annual Healthcare Conference (Business Wire)
Feb-28-25 02:22AM	Chemed Corp (CHE) Q4 2024 Earnings Call Highlights: Strong VITAS Growth Amid Roto-Rooter Challenges (GuruFocus.com)
12:28AM	Q4 2024 Chemed Corp Earnings Call (Thomson Reuters StreetEvents)
Feb-26-25 06:15PM	Chemed (CHE) Surpasses Q4 Earnings and Revenue Estimates (Zacks) +7.39%
05:15PM	Chemed: Q4 Earnings Snapshot (Associated Press Finance)
05:00PM	Chemeds (NYSE:CHE) Q4: Beats On Revenue (StockStory)
04:15PM	Chemed Reports Fourth-Quarter 2024 Results (Business Wire)
Feb-25-25 08:06AM	What To Expect From Chemeds (CHE) Q4 Earnings (StockStory)
Feb-14-25 01:30PM	Chemed Corporation Declares Quarterly Dividend of 50 Cents (Business Wire)
04:03AM	Winners And Losers Of Q3: AdaptHealth (NASDAQ:AHCO) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks (StockStory)
04:03AM	Senior Health, Home Health & Hospice Stocks Q3 Results: Benchmarking Brookdale (NYSE:BKD) (StockStory)
04:01AM	Q3 Earnings Highs And Lows: Chemed (NYSE:CHE) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks (StockStory)
Feb-13-25 01:13PM	Senior Health, Home Health & Hospice Stocks Q3 Teardown: The Pennant Group (NASDAQ:PNTG) Vs The Rest (StockStory)
04:01AM	Senior Health, Home Health & Hospice Stocks Q3 Earnings Review: Option Care Health (NASDAQ:OPCH) Shines (StockStory)
Feb-11-25 05:35PM	Chemed To Report Fourth-Quarter 2024 Earnings February 26, Related Conference Call To Be Held On February 27 (Business Wire)
04:03AM	Senior Health, Home Health & Hospice Stocks Q3 Teardown: BrightSpring Health Services (NASDAQ:BTSG) Vs The Rest (StockStory)
04:02AM	Q3 Earnings Highlights: Addus HomeCare (NASDAQ:ADUS) Vs The Rest Of The Senior Health, Home Health & Hospice Stocks (StockStory)
Jan-07-25 12:00PM	Chemed Corporation to Present at the 43rd Annual JPMorgan Healthcare Conference (Business Wire)
Dec-03-24 12:00PM	Chemed Corporation to Present at the BofA Securities 2024 Virtual Home Care Conference (Business Wire)
Nov-28-24 08:28AM	Heres Why Chemed Corporation (CHE) Rose in Q3 (Insider Monkey)
Nov-08-24 11:43AM	Chemed Corporation Board of Directors Authorizes an Additional $300 Million for Stock Repurchase and Declares Quarterly Dividend of 50 Cents (Business Wire)
Nov-05-24 12:00PM	Chemed Corporation to Present at the UBS 2024 Global Healthcare Conference (Business Wire)
Oct-31-24 03:10AM	Chemed Corp (CHE) Q3 2024 Earnings Call Highlights: VITAS Shines Amid Roto-Rooter's Challenges (GuruFocus.com)
01:54AM	Q3 2024 Chemed Corp Earnings Call (Thomson Reuters StreetEvents)
Oct-29-24 05:55PM	Chemed (CHE) Lags Q3 Earnings and Revenue Estimates (Zacks) -12.14%
04:52PM	Chemed: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Chemed Reports Third-Quarter 2024 Results (Business Wire)
Oct-01-24 01:37PM	Final Trades: Exxon, Chemed, Las Vegas Sands and the IEO (CNBC TV)
Sep-18-24 09:45AM	Why Chemed (CHE) is a Top Growth Stock for the Long-Term (Zacks)
Sep-13-24 01:46PM	Chemed To Report Third-Quarter 2024 Earnings October 29, Related Conference Call To Be Held On October 30 (Business Wire)
Sep-11-24 09:44AM	Heres Why Chemed Corporation (CHE) Declined in Q2 (Insider Monkey)
Sep-10-24 03:00PM	Insider Sale: Executive Vice President Nicholas Westfall Sells Shares of Chemed Corp (CHE) (GuruFocus.com)
Aug-23-24 11:30AM	Chemed (CHE) Up 5.7% Since Last Earnings Report: Can It Continue? (Zacks)
Aug-15-24 09:45AM	Here's Why Chemed (CHE) is a Strong Growth Stock (Zacks)
Aug-09-24 05:00PM	Insider Sale: Vice President Thomas Hutton Sells Shares of Chemed Corp (CHE) (GuruFocus.com)
05:00PM	Insider Sale: Executive Vice President Spencer Lee Sells Shares of Chemed Corp (CHE) (GuruFocus.com)
Aug-08-24 11:17AM	3 Ways to Play the Long-Term Care Crisis in 2024 (InvestorPlace)
Aug-07-24 01:45PM	Trade Tracker: Karen Firestone buys Abbott Labs, Chemed, Costar Group and sells Home Depot (CNBC TV)
Aug-02-24 11:54AM	Chemed Corporation Declares Quarterly Dividend of 50 Cents (Business Wire)
Jul-31-24 01:00PM	Insider Sale: Executive Vice President Nicholas Westfall Sells Shares of Chemed Corp (CHE) (GuruFocus.com)
Jul-30-24 09:45AM	Why Chemed (CHE) is a Top Growth Stock for the Long-Term (Zacks)
Jul-29-24 12:45PM	3 Reasons Why Growth Investors Shouldn't Overlook Chemed (CHE) (Zacks)
Jul-26-24 03:11AM	Q2 2024 Chemed Corp Earnings Call (Thomson Reuters StreetEvents)

Chemed Corp. engages in the provision of healthcare and maintenance services. It operates through the VITAS and Roto-Rooter segments. The VITAS segment offers hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers. The Roto-Rooter segment includes plumbing, drain cleaning, water restoration, and other related services to residential and commercial customers. The company was founded in 1970 and is headquartered in Cincinnati, OH.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GRACE PATRICK P	Director	Sep 09 '25	Sale	463.39	150	69,508	3,397	Sep 10 11:51 AM
Patrick P. Grace	Director	Sep 09 '25	Proposed Sale	463.78	150	69,567		Sep 09 05:10 PM
RICE THOMAS P	Director	Jul 31 '25	Proposed Sale	418.01	556	232,411		Aug 22 11:18 AM
MCNAMARA KEVIN J	president and CEO	Aug 05 '25	Sale	428.55	2,000	857,100	99,197	Aug 05 04:42 PM
MCNAMARA KEVIN J	Officer	Aug 05 '25	Proposed Sale	428.73	2,000	857,460		Aug 05 04:10 PM
WALSH GEORGE J III	Director	Aug 04 '25	Buy	417.10	200	83,420	3,523	Aug 05 03:24 PM
Westfall Nicholas Michael	Executive Vice President	Aug 04 '25	Sale	421.91	10,012	4,224,163	0	Aug 05 10:30 AM
Nicholas M Westfall	Officer	Aug 04 '25	Proposed Sale	417.85	10,012	4,183,514		Aug 04 04:50 PM
LEE SPENCER S	executive vice president	May 16 '25	Sale	577.99	1,500	866,985	14,627	May 19 09:58 AM
Westfall Nicholas Michael	Executive Vice President	May 09 '25	Option Exercise	451.72	26,088	11,784,456	33,012	May 12 02:42 PM
LEE SPENCER S	executive vice president	May 07 '25	Sale	577.86	1,500	866,790	16,127	May 08 09:13 AM
MCNAMARA KEVIN J	president and CEO	May 05 '25	Option Exercise	471.74	10,000	4,717,400	111,679	May 06 11:59 AM
MCNAMARA KEVIN J	president and CEO	May 05 '25	Sale	576.45	1,500	864,675	101,197	May 06 11:59 AM
MCNAMARA KEVIN J	Officer	May 05 '25	Proposed Sale	575.46	1,500	863,190		May 05 04:03 PM
MCNAMARA KEVIN J	president and CEO	Mar 31 '25	Sale	615.33	1,000	615,330	101,679	Apr 01 11:05 AM
MCNAMARA KEVIN J	Director	Mar 31 '25	Proposed Sale	605.70	1,000	605,700		Mar 31 03:54 PM
Witzeman Michael D	VP & Chief Financial Officer	Mar 10 '25	Option Exercise	445.35	8,796	3,917,299	13,154	Mar 11 03:12 PM
MCNAMARA KEVIN J	president and CEO	Mar 06 '25	Sale	593.67	2,000	1,187,340	102,679	Mar 07 11:03 AM
MCNAMARA KEVIN J	Director	Mar 06 '25	Proposed Sale	593.60	2,000	1,187,199		Mar 06 04:28 PM
LEE SPENCER S	executive vice president	Mar 03 '25	Sale	592.25	1,326	785,324	17,627	Mar 03 03:28 PM
LEE SPENCER S	executive vice president	Feb 14 '25	Option Exercise	553.39	1,073	593,787	19,295	Feb 18 05:22 PM
Westfall Nicholas Michael	Executive Vice President	Feb 14 '25	Option Exercise	553.39	1,473	815,143	7,582	Feb 18 05:05 PM
Witzeman Michael D	VP & Chief Financial Officer	Feb 14 '25	Option Exercise	553.39	850	470,382	4,634	Feb 18 04:49 PM
HUTTON THOMAS C	vice president	Feb 14 '25	Option Exercise	553.39	411	227,443	33,176	Feb 18 04:03 PM
MCNAMARA KEVIN J	president and CEO	Feb 14 '25	Option Exercise	553.39	5,321	2,944,588	107,056	Feb 18 03:41 PM
Judkins Brian C	VP and Chief Legal Officer	Feb 14 '25	Option Exercise	553.39	724	400,654	2,402	Feb 18 03:14 PM
Judkins Brian C	VP and Chief Legal Officer	Dec 30 '24	Buy	519.50	145	75,328	1,678	Dec 30 11:10 AM
LEE SPENCER S	executive vice president	Nov 27 '24	Sale	575.62	732	421,356	18,287	Nov 29 10:38 AM
MCNAMARA KEVIN J	president and CEO	Nov 25 '24	Sale	572.77	2,000	1,145,540	101,735	Nov 26 11:24 AM
MCNAMARA KEVIN J	Officer	Nov 25 '24	Proposed Sale	571.11	2,000	1,142,220		Nov 25 03:44 PM
LEE SPENCER S	executive vice president	Nov 22 '24	Sale	565.71	1,000	565,710	19,019	Nov 22 01:37 PM
MCNAMARA KEVIN J	president and CEO	Sep 26 '24	Sale	598.81	2,000	1,197,620	103,735	Sep 27 11:27 AM
WALSH GEORGE J III	Director	Sep 26 '24	Sale	597.47	400	238,988	3,046	Sep 27 11:17 AM
MCNAMARA KEVIN J	Director	Sep 26 '24	Proposed Sale	598.75	2,000	1,197,505		Sep 26 04:22 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CHE

Chemed Corp

Upgrade your FINVIZ experience